<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00841100</url>
  </required_header>
  <id_info>
    <org_study_id>20080675</org_study_id>
    <nct_id>NCT00841100</nct_id>
  </id_info>
  <brief_title>Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response</brief_title>
  <official_title>Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate the effect of blood phenylalanine on Kuvan responsiveness
      in the same patients with PKU when their blood phenylalanine concentrations are altered by
      diet.

      Lowering blood phenylalanine concentrations in Kuvan non-responsive patients with PKU will
      increase the frequency of Kuvan responsiveness.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">February 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of effect of blood phenylalanine on Kuvan response</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Phenylketonuria</condition>
  <arm_group>
    <arm_group_label>Kuvan and nutrition couseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kuvan</intervention_name>
    <description>20mg/kg/d, once daily</description>
    <arm_group_label>Kuvan and nutrition couseling</arm_group_label>
    <other_name>sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients with a diagnosis of phenylketonuria

          -  patients who are over the age of 4 years,

          -  patients with a fasting blood phenylalanine ≥600µmol/l

        Exclusion Criteria:

          -  female patients who are pregnant or attempting to become pregnant

          -  children under four years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis J Elsas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Louis J Elsas, MD</last_name>
    <phone>305 243 7126</phone>
    <email>lelsas@med.miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea M Wierenga, PhD</last_name>
    <phone>305 243 8122</phone>
    <email>awierenga@med.miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Biochemistry &amp; Molecular Biology</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis J Elsas, MD</last_name>
      <phone>305-243-7126</phone>
      <email>lelsas@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrea M Wierenga, PhD</last_name>
      <phone>305 243 8122</phone>
      <email>awierenga@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Andrea M Wierenga, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://bh4.org/BH4_Start.asp</url>
    <description>Website about tetrahydrobiopterin</description>
  </link>
  <reference>
    <citation>Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA, Abadie V, Harding CO, Cederbaum S, Dobbelaere D, Smith A, Dorenbaum A. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis. 2007 Oct;30(5):700-7. Epub 2007 Sep 12.</citation>
    <PMID>17846916</PMID>
  </reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2009</study_first_submitted>
  <study_first_submitted_qc>February 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2009</study_first_posted>
  <last_update_submitted>March 10, 2009</last_update_submitted>
  <last_update_submitted_qc>March 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Louis J. Elsas</name_title>
    <organization>University of Miami</organization>
  </responsible_party>
  <keyword>PKU</keyword>
  <keyword>Kuvan</keyword>
  <keyword>BH4</keyword>
  <keyword>tetrahydrobiopterin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

